Successful post-exposure prophylaxis of Ebola infected non-human primates using Ebola glycoprotein-specific equine IgG-Reference-Cited by-同舟云学术

Successful post-exposure prophylaxis of Ebola infected non-human primates using Ebola glycoprotein-specific equine IgG

Published:2017-02 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Pyankov Oleg V.,Setoh Yin Xiang,Bodnev Sergey A.,Edmonds Judith H.,Pyankova Olga G.,Pyankov Stepan A.,Pali Gabor,Belford Shane,Lu Louis,La Mylinh,Lovrecz George,Volchkova Valentina A.,Chappell Keith J.,Watterson Daniel,Marsh Glenn,Young Paul R.,Agafonov Alexander A.,Farmer Jillann F.,Volchkov Victor E.,Suhrbier Andreas,Khromykh Alexander A.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep41537.pdf

Reference47 articles.

1. Cardile, A. P., Downey, L. G., Wiseman, P. D., Warren, T. K. & Bavari, S. Antiviral therapeutics for the treatment of Ebola virus infection. Curr Opin Pharmacol 30, 138–143 (2016).

2. Zhang, Q. et al. Potent neutralizing monoclonal antibodies against Ebola virus infection. Sci Rep 6, 25856 (2016).

3. Flyak, A. I. et al. Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus Infection. Cell 164, 392–405 (2016).

4. Qiu, X. et al. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature 514, 47–53 (2014).

5. Qiu, X. et al. Two-mAb cocktail protects macaques against the Makona variant of Ebola virus. Sci Transl Med 8, 329ra333 (2016).

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential epidemic threat of Ebola virus and the development of a preventive vaccine;Journal of Biosafety and Biosecurity;2023-06

2. Production of hyperimmune sera: a study of digestion and fractionation methodologies for the purification process of heterologous immunoglobulins;Toxin Reviews;2022-09-20

3. A platform technology for generating subunit vaccines against diverse viral pathogens;Frontiers in Immunology;2022-08-18

4. Equine immunoglobulin fragment F(ab’)2 displays high neutralizing capability against multiple SARS-CoV-2 variants;Clinical Immunology;2022-04

5. Polyclonal F(ab’)2 fragments of equine antibodies raised against the spike protein neutralize SARS-CoV-2 variants with high potency;iScience;2021-11